Severe cutaneous reactions caused by barbiturates in seven Iranian children

International Journal of Dermatology

Volumn 48, Issue 11, 2009, Pages 1254-1261

  Mamishi, Setareh ^a   Fattahi, Fatemeh ^a   Pourpak, Zahra ^a   Aghaee, Farzaneh Mirza ^a   Moinfar, Zeinab ^a   Mohammadi, Mahmoud ^a   Ashrafi, Mahmoud ^a   Moin, Mostafa ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CORTICOSTEROID; DEXAMETHASONE; IMMUNOGLOBULIN; NYSTATIN; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ANOREXIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONVULSION; COUGHING; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DIZZINESS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHEMA MULTIFORME; FEMALE; FEVER; HUMAN; INCIDENCE; IRAN; LABORATORY TEST; MALAISE; MALE; MORBIDITY; MORTALITY; MUCOSA; PAIN; PRESCHOOL CHILD; RASH; SCHOOL CHILD; SEIZURE; SINGLE DRUG DOSE; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; TOXIC EPIDERMAL NECROLYSIS;

ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; EPIDERMAL NECROLYSIS, TOXIC; EPILEPSY; FEMALE; HUMANS; INFANT; IRAN; MALE; PHENOBARBITAL; SEVERITY OF ILLNESS INDEX; STEVENS-JOHNSON SYNDROME;

EID: 70449435528     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03561.x     Document Type: Article

References (23)

1. Forman R, Koren G, Shear NH. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Saf 2002, 25:965-972.
2. Chan HL, Stern RS, Arndt KA. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 1990, 126:43-47.
3. Becker DS. Toxic epidermal necrolysis. Lancet 1998, 351:1417-1420.
4. Mockenhaupt M, Messenheimer J, Tennis P. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology 2005, 64:1134-1138.
5. Arora VK, Venubabu K. Cotrimoxazole induced toxic epidermal necrolysis in a suspected case of Pneumocystis carinii pneumonia with human immunodeficiency virus infection. Indian J Chest Dis Allied Sci 1998, 40:125-129.
6. Cohen V, Schwartz RA. Toxic epidermal necrolysis. Int J Dermatol 2002, 41:116-118.
7. Arca E, Kose O, Erbil AH. A 2-year-old girl with Stevens-Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin. Pediatr Dermatol 2005, 22:317-320.
8. Brambilla G, Brucato F, Angrisano A. Treatment of toxic epidermal necrolysis (TEN). Ann Burns Fire Disasters 2002, 15:17-21.
9. Spies M, Sanford AP, Aili Low JF. Treatment of extensive toxic epidermal necrolysis in children. Pediatrics 2001, 108:1162-1168.
10. Trent JT, Bowes LE, Romanelli P. Toxic epidermal necrolysis of the scalp following anticonvulsant use and cranial irradiation. J Cutan Med Surg 2001, 5:475-478.
11. Creamer JD, Whittaker SJ, Kerr-Muir M. Phenytoin-induced toxic epidermal necrolysis: a case report. Clin Exp Dermatol 1996, 21:116-120.
12. Fattahi F, Pourpak Z, Moin M. Adverse drug reactions in hospitalized children in a department of infectious diseases. J Clin Pharmacol 2005, 45:1313-1318.
13. Wilkins MR. What do we want from proteomics in the detection and avoidance of adverse drug reactions. Toxicol Lett 2002, 127:245-249.
14. Watanakunakorn P, Brodell RT. Toxic epidermal necrolysis. A widespread, life-threatening blistering reaction. Postgrad Med 2000, 107:29-30.
15. Roujeau JC, Revuz J. Toxic epidermal necrolysis: an expanding field of knowledge. J Am Acad Dermatol 1994, 31:301-302.
16. Fattahi F, Pourpak Z, Moin M. Adverse cutaneous reactions to drugs in hospitalized children in a Department of Infectious Disease. J Invest Dermatol 2005, 125:A85-A85. (500 Suppl.)
17. Aguiar D, Pazo R, Duran I. Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider. J Neurooncol 2004, 66:345-350.
18. Roujeau JC, Kelly JP, Naldi L. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995, 333:1600-1607.
19. Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev 2001, 53:357-379.
20. Supple KG, Liberio JN. Toxic epidermal necrolysis: a critical care challenge. Crit Care Nurse 1997, 17:47-55.
21. Ghislain PD, Roujeau JC. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J 2002, 8:5.
22. Roujeau JC, Guillaume JC, Fabre JP. Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-85. Arch Dermatol 1990, 126:37-42.
23. Wong KC, Kennedy PJ, Lee S. Clinical manifestations and outcomes in 17 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis. Australas J Dermatol 1999, 40:131-134.